U.S. exemption from Europe's ban on spongiform-risk materials sought by USTR.
This article was originally published in The Gray Sheet
Executive Summary
U.S. EXEMPTION FROM EUROPE'S BAN ON SPONGIFORM-RISK MATERIALS SOUGHT by the U.S. Trade Representative. USTR plans to press Europe to exempt medical devices, pharmaceuticals, cosmetics and other U.S. products from a European ban on use of materials at risk of contamination by transmissible spongiform encephalopathies (TSE). The ban, imposed by a July decision of the European Commission, is slated to go into effect Jan. 1.